Medicine for treating prostate hyperplasia

A prostatic hyperplasia and drug technology, applied in the field of drugs for the treatment of prostatic hyperplasia, can solve the problems of inability to comprehensively improve symptoms, morbidity and complications, lack of prostatic hyperplasia, etc., and achieve rapid effect, quick effect and convenient administration Effect

Inactive Publication Date: 2010-01-13
陈静静
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, most of the drugs for the treatment of benign prostatic hyperplasia are mainly oral drugs, but the course of treatment is long, easy to relapse, limited curative effect, side effects are large, and cannot comprehensively improve symptoms
Surgical therapy is prone to serious complications. Old and frail patients with benign prostatic hyperplasia have more postoperative morbidity and complications
Therefore, there is still a lack of an effective comprehensive treatment drug for benign prostatic hyperplasia.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] The medicine for treating prostatic hyperplasia of the present invention is made of the following raw materials: 15 grams of mulberry leaves, 15 grams of ginkgo leaves, 4 grams of Gynostemma pentaphylla, 11 grams of wheat bran, 5 grams of Evodia, 7 grams of bergamot, 7 grams of Perrin, and Huoxiang 12 grams, Magnolia officinalis 7 grams, Xuanfuhua 6 grams, Gualou 5 grams, red ginseng 11 grams, salvia miltiorrhiza 8 grams, red peony 9 grams, Chuanxiong 9 grams, Panax notoginseng 13 grams, Yuanhu 9 grams, Ophiopogon japonicus 12 gram, 9 grams of woody fragrance, 12 grams of safflower, 11 grams of astragalus, 8 grams of amber, 4 grams of cinnamon, 7 grams of keel, 12 grams of angelica, 9 grams of Puhuang, 7 grams of schisandra, 7 grams of peach kernels, 3 grams of agarwood, oyster 7 grams.

[0011] Preparation method: Combine the above-mentioned medicines that need to be matched together, and sterilize the medicines with ultraviolet light; then put them in an oven to dry t...

Embodiment 2

[0014] The medicine for treating prostatic hyperplasia of the present invention is made of the following raw materials: 10 grams of mulberry leaves, 10 grams of ginkgo leaves, 3 grams of Gynostemma pentaphylla, 10 grams of wheat bran, 4 grams of Evodia rutaecarpa, 6 grams of bergamot, 6 grams of Perrin, and Huoxiang 10 grams, 6 grams of Magnolia officinalis, 5 grams of Xuanfuhua, 4 grams of Trichosanthes, 10 grams of red ginseng, 6 grams of salvia miltiorrhiza, 8 grams of red peony, 8 grams of Chuanxiong, 12 grams of Panax notoginseng, 8 grams of Yuanhu, 10 grams of Ophiopogon japonicus gram, 8 grams of woody fragrance, 10 grams of safflower, 10 grams of astragalus, 7 grams of amber, 3 grams of cinnamon, 6 grams of keel, 10 grams of angelica, 8 grams of Puhuang, 6 grams of schisandra, 6 grams of peach kernels, 2 grams of agarwood, oyster 6 grams.

[0015] All the other are identical with embodiment 1.

Embodiment 3

[0017] The medicine for treating prostatic hyperplasia of the present invention is made of the following raw materials: 20 grams of mulberry leaves, 20 grams of ginkgo leaves, 5 grams of Gynostemma pentaphyllum, 12 grams of wheat bran, 6 grams of Evodia rutaecarpa, 8 grams of bergamot, 8 grams of Perrin, and Huoxiang 14 grams, Magnolia officinalis 8 grams, Inula 7 grams, Trichosanthes 6 grams, red ginseng 12 grams, Salvia miltiorrhiza 10 grams, red peony root 10 grams, Chuanxiong 10 grams, Panax notoginseng 14 grams, Yuanhu 10 grams, Ophiopogon japonicus 14 gram, 10 grams of woody fragrance, 14 grams of safflower, 12 grams of astragalus, 9 grams of amber, 5 grams of cinnamon, 8 grams of keel, 14 grams of angelica, 10 grams of Puhuang, 8 grams of schisandra, 8 grams of peach kernels, 4 grams of agarwood, oyster 8 grams.

[0018] All the other are identical with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating prostate hyperplasia, which is prepared from the following raw materials according to parts by weight: 10-20 parts of mulberry leaf, 10-20 parts of ginkgo leaf, 3-5 parts of gynostemma pentaphylla, 10-12 parts of wheat bran, 4-6 parts of evodia rutaecarpa, 6-8 parts of fructus citri sarcodactylis, 6-8 parts of herba eupatorii, 10-14 parts of wrinkled gianthyssop, 6-8 parts of officinal magnolia, 5-7 parts of inula flower, 4-6 parts of snakegourd fruit, 10-12 parts of red ginseng, 6-10 parts of radix salviae miltiorrhizae, 8-10 parts of red peony root, 8-10 parts of rhizoma ligustici wallichii, 12-14 parts of radix notoginseng, 8-10 parts of rhizoma corydalis, 10-14 parts of ophiopogon root and 8-10 parts of rosa banksiae. The invention has the advantages of small toxic or side effect, convenient taking, easy absorption, quick acting, good curative effect, low price and quick function and conforms to the national relevant standard by inspection. The clinical application observation confirms that the acting is quick. Compared with the traditional medicines, such as Qianliekang and the like, the traditional Chinese medicine preparation for treating the prostate hyperplasia disease has the characteristics of long acting, quick acting and high efficiency.

Description

(1) Technical field [0001] The invention relates to a medicine for treating benign prostatic hyperplasia. (2) Background technology [0002] Prostatic hyperplasia is a frequently-occurring disease that mostly occurs in middle-aged and elderly comrades. It is manifested as frequent urination, fine urinary stream or difficulty in urinating, and even urinary retention, which brings great pain to patients. At present, most of the drugs for the treatment of benign prostatic hyperplasia are oral drugs, but the course of treatment is long, easy to relapse, curative effect is limited, side effects are large, and the symptoms cannot be improved comprehensively. Surgical therapy is prone to serious complications. Old and frail patients with benign prostatic hyperplasia have more postoperative morbidity and complications. Therefore, there is still a lack of an effective comprehensive treatment drug for benign prostatic hyperplasia. (3) Contents of the invention [0003] In order to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P13/08A61K35/10A61K35/02
Inventor 宋华陈静静
Owner 陈静静
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products